Understanding how effective 'induced after-death communication' therapy is in helping people deal with grief and what factors influence the results

Efficacy and predictors of outcome of Induced After-Death Communication (IADC) therapy in treating grief

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN10485391

Enrollment

Registered

2025-03-24

Start date

2023-09-10

Completion date

Unknown

Last updated

2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Treatment of grief in bereaved adults Other

Interventions

Bereaved English-speaking adults in Australia were provided with Induced After-Death Communication (IADC) Therapy following a one-month waitlist (control) period.

Eligibility

Sex/Gender

All

Age

18 Years to 110 Years

Inclusion criteria

Inclusion criteria: 1. English-speaking 2. Adults (>18 years) 3. Within Australia

Exclusion criteria

Exclusion criteria: 1. Suicidality 2. If less than six months had passed since the loss 3. If clients were unwilling or unable to tolerate high levels of emotion or distress in confronting their grief and sadness.

Design outcomes

Primary

Measure	Time frame
1. Grief Symptoms as measured using the International Prolonged Grief Disorder Scale at Time 1 (start of waitlist period), Time 2 (end of one-month baseline waitlist period), and Time 4 (one-month follow-up post-treatment). 2. Average Daily Sadness - subjective self-report on a 0-10 scale at Time 1 (start of waitlist period), Time 2 (end of one-month baseline waitlist period), and Time 4 (one-month follow-up post-treatment).	—

Measure

Time frame

1. Grief Symptoms as measured using the International Prolonged Grief Disorder Scale at Time 1 (start of waitlist period), Time 2 (end of one-month baseline waitlist period), and Time 4 (one-month follow-up post-treatment). 2. Average Daily Sadness - subjective self-report on a 0-10 scale at Time 1 (start of waitlist period), Time 2 (end of one-month baseline waitlist period), and Time 4 (one-month follow-up post-treatment).

—

Secondary

Measure	Time frame
1. Depression as measured by the Depression, Anxiety & Stress Scale (DASS-21) 2. Occurrence of after-death communication (ADC) as measured by self-report at Time 3 (immediately posttreatment) and Time 4 (one month follow-up) 3. Ongoing bonds as measured by the Continuing Presence subscale of the Ongoing Attachment Inventory at Time 1 (start of waitlist period), Time 2 (end of one-month baseline waitlist period), and Time 4 (one-month follow-up post-treatment). 4. Grief as measured by the Hogan Grief Reaction Checklist at Time 1 (start of waitlist period), Time 2 (end of one-month baseline waitlist period), and Time 4 (one-month follow-up post-treatment).	—

Measure

Time frame

1. Depression as measured by the Depression, Anxiety & Stress Scale (DASS-21) 2. Occurrence of after-death communication (ADC) as measured by self-report at Time 3 (immediately posttreatment) and Time 4 (one month follow-up) 3. Ongoing bonds as measured by the Continuing Presence subscale of the Ongoing Attachment Inventory at Time 1 (start of waitlist period), Time 2 (end of one-month baseline waitlist period), and Time 4 (one-month follow-up post-treatment). 4. Grief as measured by the Hogan Grief Reaction Checklist at Time 1 (start of waitlist period), Time 2 (end of one-month baseline waitlist period), and Time 4 (one-month follow-up post-treatment).

—

Countries

Australia

Contacts

Public ContactThomas Nehmy

tom.nehmy@adelaide.edu.au+61 8 8313 4763

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Aug 25, 2026